Biovie Inc. (BIVIW) — 10-Q Filings
All 10-Q filings from Biovie Inc.. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (6)
-
BIOVIE's Q3 Loss Widens Amid R&D Surge, Cash Boosted by Equity Raise
— Nov 10, 2025 Risk: high
BIOVIE INC. (BIVIW) reported a net loss of $5,087,557 for the three months ended September 30, 2025, an increase from a net loss of $4,152,032 for the same peri -
BioVie Inc. Files Q1 2025 10-Q
— May 12, 2025 Risk: medium
BioVie Inc. filed its 10-Q for the period ending March 31, 2025, reporting on its financial performance. The company, formerly NanoAntibiotics, Inc., is incorpo -
BioVie Inc. Files 10-Q for Period Ending Dec 31, 2024
— Feb 11, 2025 Risk: medium
BioVie Inc. filed its 10-Q for the period ending December 31, 2024. The company reported financial results for the second quarter and the first six months of fi -
BioVie Inc. Files 10-Q for Q3 2024
— Nov 13, 2024 Risk: medium
BioVie Inc. filed its 10-Q for the period ending September 30, 2024. The company, formerly known as NanoAntibiotics, Inc., is incorporated in Nevada and operate -
BioVie Inc. Files 10-Q for Period Ending March 31, 2024
— May 14, 2024 Risk:
BIOVIE INC. (BIVIW) filed a Quarterly Report (10-Q) with the SEC on May 14, 2024. BioVie Inc. filed its quarterly report (10-Q) for the period ending March 31, -
BIOVIE INC. Files 10-Q for Period Ending December 31, 2023
— Feb 13, 2024 Risk:
BIOVIE INC. (BIVIW) filed a Quarterly Report (10-Q) with the SEC on February 13, 2024. BIOVIE INC. filed a 10-Q report for the period ending December 31, 2023.
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX